tiprankstipranks
Fulgent Genetics (FLGT)
:FLGT
US Market

Fulgent Genetics (FLGT) Income Statement

Compare
1,625 Followers

Fulgent Genetics Income Statement

Last quarter (Q3 2024), Fulgent Genetics's total revenue was $71.74M, a decrease of -15.28% from the same quarter last year. In Q3, Fulgent Genetics's net income was $-14.65M. See Fulgent Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 289.21M$ 618.97M$ 992.58M$ 421.71M$ 32.53M
Gross Profit
$ 104.46M$ 366.90M$ 777.05M$ 331.90M$ 18.42M
Operating Expenses
$ 299.40M$ 185.40M$ 101.10M$ 41.75M$ 18.85M
Depreciation and Amortization
$ 26.14M$ 36.91M$ 12.16M$ 3.37M$ 2.52M
EBITDA
$ -46.55M$ 221.59M$ 675.95M$ 290.16M$ 1.68M
Operating Income
$ -72.69M$ 178.53M$ 675.95M$ 290.16M$ -428.00K
Other Income/Expenses
$ -101.39M$ 5.50M$ 1.35M$ 1.53M$ 837.00K
Pretax Income
$ -174.09M$ 184.03M$ 677.30M$ 291.68M$ 409.00K
Net Income
$ -167.82M$ 143.40M$ 507.36M$ 214.31M$ 366.00K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.63$ 4.76$ 17.13$ 9.64$ 0.02
Diluted EPS
$ -5.63$ 4.63$ 16.26$ 9.09$ 0.02
Weighted Average Shares Outstanding
29.78M 30.10M 29.41M 22.69M 18.71M
Weighted Average Shares Outstanding (Diluted)
29.78M 30.96M 30.98M 24.06M 18.71M
Currency in USD

Fulgent Genetics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis